These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10352333)

  • 1. Influence of aspirin on platelet count and volume in humans.
    Erhart S; Beer JH; Reinhart WH
    Acta Haematol; 1999; 101(3):140-4. PubMed ID: 10352333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects.
    Maenthaisong R; Tacconelli S; Sritara P; Del Boccio P; Di Francesco L; Sacchetta P; Archararit N; Aryurachai K; Patrignani P; Suthisisang C
    Int J Immunopathol Pharmacol; 2013; 26(2):403-17. PubMed ID: 23755755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
    Nadar S; Blann AD; Lip GY
    Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial.
    Tang YD; Rinder HM; Katz SD
    Am Heart J; 2007 Sep; 154(3):494.e1-7. PubMed ID: 17719296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjects.
    Jermany J; Branson J; Schmouder R; Guillaume M; Rordorf C
    J Clin Pharmacol; 2005 Oct; 45(10):1172-8. PubMed ID: 16172182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of policosanol, aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers.
    Arruzazabala ML; Valdés S; Más R; Carbajal D; Fernández L
    Pharmacol Res; 1997 Oct; 36(4):293-7. PubMed ID: 9425618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.
    Guthikonda S; Lev EI; Patel R; DeLao T; Bergeron AL; Dong JF; Kleiman NS
    J Thromb Haemost; 2007 Mar; 5(3):490-6. PubMed ID: 17319904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers.
    Wilner KD; Rushing M; Walden C; Adler R; Eskra J; Noveck R; Vargas R
    J Clin Pharmacol; 2002 Sep; 42(9):1027-30. PubMed ID: 12211219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin Induces platelet apoptosis.
    Zhao L; Zhang W; Chen M; Zhang J; Zhang M; Dai K
    Platelets; 2013; 24(8):637-42. PubMed ID: 23301845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.
    Ohmori T; Yatomi Y; Nonaka T; Kobayashi Y; Madoiwa S; Mimuro J; Ozaki Y; Sakata Y
    J Thromb Haemost; 2006 Jun; 4(6):1271-8. PubMed ID: 16706971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
    Terres W; Schuster O; Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers.
    Van Ryn J; Kink-Eiband M; Kuritsch I; Feifel U; Hanft G; Wallenstein G; Trummlitz G; Pairet M
    J Clin Pharmacol; 2004 Jul; 44(7):777-84. PubMed ID: 15199082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.